[7th Conference on Retroviruses and Opportunistic Infections].
De Wit
S
S
Service des Maladies Infectieuses, C.H.U. Saint-Pierre, U.L.B.
D016915:AIDS Vaccines; D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D019427:HIV Integrase / Q000378:metabolism; D006801:Humans; D007165:Immunosuppression Therapy; D019429:Integrase Inhibitors / Q000627:therapeutic use; D008060:Lipodystrophy / Q000139:chemically induced; D010024:Osteoporosis / Q000209:etiology; D011480:Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D014760:Viral Fusion Proteins / Q000037:antagonists & inhibitors
D016915:AIDS Vaccines; D019380:Anti-HIV Agents; D019429:Integrase Inhibitors; D011480:Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D014760:Viral Fusion Proteins; D019427:HIV Integrase
7éme conférence sur les rétrovirus et les infections opportunistes.